Past 10 year's financial track record analysis by Moneyworks4me indicates that Niva Bupa Health Insurance Company Ltd is a average quality company.
The key valuation ratios of Niva Bupa Health Insurance Company Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Niva Bupa Health Insurance Company Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -59.9% | -36.2% | -1.7% | 9.3% | -18.7% | -20.2% | -10.8% | -29.5% | 1.4% | 4.8% | - |
| Value Creation Index ⓘ | -5.4 | -3.7 | -1.1 | -0.3 | -2.4 | -2.5 | -1.8 | -3.2 | -0.9 | -0.6 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - |
| Adj EPS ⓘ | -1.2 | -0.8 | -0 | 0.3 | -0.5 | -0.6 | -0.4 | -1.4 | 0.1 | 0.5 | 0.5 |
| YoY Gr. | - | NA | NA | NA | -296% | NA | NA | NA | NA | 500% | - |
| BVPS (₹) ⓘ | 2.2 | 2.3 | 2.5 | 2.8 | 2.7 | 3.1 | 4.3 | 3.6 | 5.5 | 12.1 | 22.3 |
| Adj Net Profit ⓘ | -93.3 | -68.5 | -3.7 | 22.8 | -48.4 | -61.6 | -49.7 | -197 | 12.5 | 81.9 | 82 |
| Cash Flow from Ops. ⓘ | -47.1 | -1.9 | 8.4 | 15.1 | 94.2 | 107 | 257 | 338 | 593 | 813 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | NA | ||||
| Adj EPS ⓘ | NA | NA | NA | 500% | ||||
| BVPSⓘ | 21.1% | 35.1% | 41.4% | 119.3% | ||||
| Share Price | - | - | - | - | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Return on Equity has increased versus last 3 years average to 2.60%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 0.5 | - |
| TTM Sales (₹ Cr.) | 0 | - |
| BVPS (₹.) ⓘ | 22.3 | - |
| Reserves (₹ Cr.) ⓘ | 2,252 | - |
| P/BV ⓘ | 3.31 | - |
| PE ⓘ | 165.06 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 69.20 / 80.94 |
| All Time Low / High (₹) | 69.20 / 80.94 |
| Market Cap (₹ Cr.) | 13,511 |
| Equity (₹ Cr.) | 1,827 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 21 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income From Investments | 16 | 18 | 18 | 21 | 22 | 28 | 30 | 38 | 56 | 138 |
| Other Income ⓘ | 0 | 0 | 1 | 3 | 0 | 0 | 0 | 7 | 6 | 3 |
| Expenses | 2 | 1 | 108 | 110 | 140 | 157 | 178 | 284 | 400 | 245 |
| Profit Before Tax | -93 | -68 | -4 | 23 | -48 | -62 | -50 | -197 | 13 | 82 |
| Tax ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -93 | -68 | -4 | 23 | -48 | -62 | -50 | -197 | 13 | 82 |
| Adjusted EPS (₹) | -1.18 | -0.76 | -0.04 | 0.25 | -0.49 | -0.55 | -0.37 | -1.40 | 0.08 | 0.48 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Share Capital ⓘ | 791 | 898 | 926 | 926 | 981 | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 |
| Reserve and Surplus | -621 | -689 | -693 | -670 | -719 | -780 | -773 | -901 | -680 | 350 |
| Fair Value A/C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | -3 | 1 |
| Borrowings ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Policy Holders Fund | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Funds For Appropriations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities ⓘ | 170 | 209 | 233 | 256 | 262 | 346 | 577 | 756 | 1,078 | 2,301 |
Assets | ||||||||||
| Investment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Net block | 30 | 22 | 32 | 37 | 30 | 39 | 46 | 49 | 52 | 58 |
| Total Assets ⓘ | 170 | 209 | 233 | 256 | 262 | 346 | 577 | 756 | 1,078 | 2,301 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | -47 | -2 | 8 | 15 | 94 | 107 | 257 | 338 | 593 | 813 |
| PBT ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjustment ⓘ | -12 | 51 | 79 | 106 | 166 | 215 | 449 | 606 | 1,142 | 1,304 |
| Changes in Working Capital ⓘ | 3 | 2 | -1 | -0 | -0 | -1 | -1 | -24 | -6 | -5 |
| Tax Paid ⓘ | -38 | -55 | -69 | -91 | -72 | -107 | -191 | -245 | -543 | -487 |
| Cash Flow From Investing Activity ⓘ | -77 | -104 | -24 | -43 | -120 | -303 | -374 | -761 | -829 | -1,882 |
| Capex | -16 | -4 | -21 | -20 | -13 | -30 | -28 | -29 | -38 | -33 |
| Net Investments | -86 | -128 | -43 | -69 | -151 | -325 | -420 | -833 | -955 | -2,073 |
| Others ⓘ | 25 | 28 | 40 | 46 | 43 | 52 | 74 | 101 | 164 | 224 |
| Cash Flow From Financing Activityⓘ | 122 | 108 | 28 | 0 | 55 | 145 | 280 | 374 | 280 | 1,110 |
| Net Proceeds from Shares ⓘ | 122 | 108 | 28 | 0 | 55 | 145 | 280 | 127 | 311 | 1,137 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27 | -27 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 247 | -4 | 0 |
| Net Cash Flow ⓘ | -2 | 1 | 12 | -28 | 29 | -51 | 164 | -49 | 43 | 41 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | ||||||||||
| ROCE (%) | ||||||||||
| Asset Turnover Ratio | 2.02 | 2.08 | 2.46 | 2.35 | 2.54 | 2.76 | 2.49 | 2.63 | 2.9 | 2.26 |
| PAT to CFO Conversion(x) | N/A | N/A | N/A | 0.65 | N/A | N/A | N/A | N/A | 45.62 | 9.91 | Working Capital Days |
| Receivable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Niva Bupa Health Insurance Limited was originally incorporated as ‘Max Bupa Health Insurance Limited’ at New Delhi as a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated September 5, 2008, issued by the Assistant Registrar of Companies, National Capital Territory of Delhi and Haryana and was granted its certificate for commencement of business on December 23, 2008 by the Deputy Registrar of Companies, National Capital Territory of Delhi and Haryana. Thereafter, the name of the company was changed to ‘Max Bupa Health Insurance Company Limited’, upon a request by the IRDAI, pursuant to a fresh certificate of incorporation dated July 30, 2009 issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana. The company was required to discontinue using the ‘Max’ brand in its name, pursuant to Max India Limited ceasing to hold Equity Shares in the company. Hence, the name of the company was changed to ‘Niva Bupa Health Insurance Company Limited’ pursuant to a fresh certificate of incorporation dated July 5, 2021 issued by the Registrar of Companies - Delhi.
Further, the company was granted its first certificate to carry out the business of general insurance by a certificate dated February 15, 2010 given by the IRDAI which was renewed on an annual basis under Section 3A of the Insurance Act. Pursuant to an amendment to Section 3A of the Insurance Act with effect from December 26, 2014, the process of annual renewal of certificate of registration was discontinued. Accordingly, the certificate of renewal of registration as issued to the company on February 25, 2014 continues to be in effect.
The company is a standalone health insurer (SAHI) strategically focused on the retail health market. The company is one of India’s largest and fastest growing SAHIs. It also offers personal accident and travel insurance products to its customers. Its purpose is to ‘give every Indian the confidence to access the best healthcare’. It aims to achieve this purpose through its health insurance products and services that enable customers to navigate their healthcare journey, by providing them access to a holistic health ecosystem.
Responding to the evolving needs of its customers years of operations, it has built a track record of product innovation catering to a range of customer groups. It offers its customers the ability to access a comprehensive health ecosystem and service capabilities via its ‘Niva Bupa Health’ mobile application and website, thereby offering them a holistic proposition. This application provides its customers access to a range of healthcare solutions including diagnostics, digital consultation, annual health check-ups and health education content. Customers can also undertake claims submission, policy servicing and track health parameters through this application. Through its diverse and evolving product suite and its ‘Niva Bupa Health’ mobile application and website, it aims to provide its customers access to a range of healthcare and disease management solutions.
Business area of the company
The company is a standalone health insurer (SAHI) strategically focused on the retail health market. It also offers personal accident and travel insurance products to its customers.
Products of the company
Awards and accreditations
History and milestones
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
FREE Become a savvy and confident
stock investor.
Hurry, limited to the first 10 users today!
Download APP
